HIV / AIDS in the News

GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff - Yahoo Finance

 

Natural Killer Cell Education Leaves Lasting Imprints on the Persistent HIV Reservoir - Bioengineer.org

 

Thailand faces its 2030 HIV target with youth infections still high - Nation Thailand

 

HIV Status Splits Cancer Screening Patterns for Anal and Cervical Tumors - Bioengineer.org

 

Group Screens Over 300 Beneficiaries for Hepatitis, HIV at Kwara Orphanages - Real Broadcasting Network

 

HIV, overcrowding and suicide: Gauhati HC flags ‘grim picture’ of Assam jails, seeks govt response - The Times of India

 

Vietnamese Camillian Priest Ministers to Children Living With HIV, Sees Communication as Life Witness - rvasia.org

 

'People are still afraid of those three letters': Fighting the stigma of HIV - NPR

 

Wistar Institute Wins $15M+ NIH Investment to Advance HIV Cure Research Strategies - PHILADELPHIA.Today

 

Philadelphia center offers local HIV support and testing - KTALnews.com

 

Philadelphia center offers local HIV support and testing - Yahoo

 

ASUN Senate Recognizes National Youth HIV/AIDS Awareness Day - nevadasagebrush.com

 

Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales - Yahoo Finance

 

A conversation with Sandra A. Springer, M.D., about the power of patient autonomy in HIV treatment and prevention - Managed Healthcare Executive

 

Cognitive decline in HIV associated with mitochondrial inefficiency, study finds - Medical Xpress

 

Health Matters: Ottawa announces $5M in funding to support HIV prevention and support services - Global News

 

How Miller School of Medicine Researchers are Advancing HIV and Healthy Aging Research - University of Miami

 

Activist Lluvia Ramirez on her journey of HIV advocacy and community activism - Windy City Times

 

HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir - pharmaceutical-technology.com

 

Cancer Drug Tested Against Hidden HIV Cells - Legal Reader

 

HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir - Yahoo

 

Orlando Mayor Buddy Dyer to Receive Chuck Hummer Visionary Award for Longstanding HIV/AIDS Advocacy - EIN Presswire

 

Why Dr. Noc is joining forces with MSF to call for access to HIV medicine - Doctors Without Borders

 

Breakthrough HIV Drug Blocked as Funding Model Struggles with Modern Medicine - distilledpost.com

 

Key facts: Gilead Sciences, Inc. BIKTARVY ~52% U.S. HIV; HSBC PT $175 - TradingView

 

Russian scientists create rare-earth cation-based HIV treatment, eye three patents - Новости GxP

 

Mpox (Formerly Known as Monkeypox) in Dermatological Practice: Presentation of a Series of Four Clinical Cases at a Referral Hospital - Cureus

 

Federal government promises $5M for HIV supports - CBC

 

$5M for HIV prevention services - CTV News

 

HIV i-Base | Macaque study eradicates simian HIV (SHIV) with combination treatment in very early infection - European AIDS Treatment Group